person · Reporting owner

Klein Peter S

Disclosed activity across 6 companies

Tapewire entity: 12811
SEC CIK: 0001478007

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Denali Therapeutics Inc.DNLI · Entity 1735	Director	June 03, 2026	June 05, 2026
F5, INC.FFIV · Entity 839	Director	March 12, 2025	March 14, 2025
MICROSOFT CORPMSFT · Entity 1016	Chief Financial Officer	September 10, 2012	September 12, 2012
Palladyne AI Corp.STRC · Entity 6068	Director	June 14, 2023	June 16, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Denali Therapeutics Inc.

Report date June 03, 2026 · Filed June 05, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	33,941	Reported balance After 2026-06-03 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2026-06-03 · Grant · Acquired 6,408 · Balance 33,941 F1: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2: Includes 6,408 unvested RSUs.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.66 · Expires 2036-06-03	Direct	19,226	Reported balance After 2026-06-03 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-06-03 · Grant · Acquired 19,226 · Balance 19,226 F3: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2: Includes 6,408 unvested RSUs.

F3: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F5, INC.

Report date March 12, 2025 · Filed March 14, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	13,333	Reported balance After 2025-03-12 transaction · row 1 1 source row Row 1 · 2025-03-12 · Exercise / conversion · Acquired 1,309 · Balance 13,333
Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2025-03-12 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2025-03-12 · Exercise / conversion · Disposed 1,309 · Balance 0 F1: Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date. F2: Restricted Stock Units will fully vest on the first business day prior to the date of the annual shareholder meeting for fiscal 2024 (to be held in 2025) if the reporting person continues to serve as a director on the vest date, and the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date. F3: If the reporting person continues to provide services to the Company through the vest date, the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date.
Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	934	Reported balance After 2025-03-13 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2025-03-13 · Grant · Acquired 934 · Balance 934 F1: Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date. F4: Restricted Stock Units will fully vest on the first business day prior to the date of the annual shareholder meeting for fiscal 2025 (to be held in 2026) if the reporting person continues to serve as a director on the vest date, and the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date. F3: If the reporting person continues to provide services to the Company through the vest date, the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date.

F2: Restricted Stock Units will fully vest on the first business day prior to the date of the annual shareholder meeting for fiscal 2024 (to be held in 2025) if the reporting person continues to serve as a director on the vest date, and the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date.

F3: If the reporting person continues to provide services to the Company through the vest date, the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date.

F4: Restricted Stock Units will fully vest on the first business day prior to the date of the annual shareholder meeting for fiscal 2025 (to be held in 2026) if the reporting person continues to serve as a director on the vest date, and the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date.

MICROSOFT CORP

Report date September 10, 2012 · Filed September 12, 2012

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	471,016	Reported balance After 2012-09-10 transaction · row 1 1 source row Row 1 · 2012-09-10 · Grant · Acquired 123,297 · Balance 471,016 F1: Represents stock award for fiscal year 2013 performance that will vest over 4 years at the rate of 25% starting on August 31, 2013, and then at the rate of 25% on each August 31 thereafter, subject to continued employment.

Filing footnotes · ownership attribution and instrument terms

F1: Represents stock award for fiscal year 2013 performance that will vest over 4 years at the rate of 25% starting on August 31, 2013, and then at the rate of 25% on each August 31 thereafter, subject to continued employment.

Palladyne AI Corp.

Report date June 14, 2023 · Filed June 16, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	265,066	Reported balance After 2023-06-14 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2023-06-14 · Grant · Acquired 195,059 · Balance 265,066 F1: Includes 195,059 restricted stock units ("RSUs"), each RSU representing the right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of (i) the first anniversary of the date the award is granted or (ii) the day prior to the date of the next annual meeting of the Issuer's stockholders following the date the award was granted, in each case, subject to the Reporting Person continuing to be a Service Provider through the applicable vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Includes 195,059 restricted stock units ("RSUs"), each RSU representing the right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of (i) the first anniversary of the date the award is granted or (ii) the day prior to the date of the next annual meeting of the Issuer's stockholders following the date the award was granted, in each case, subject to the Reporting Person continuing to be a Service Provider through the applicable vesting date.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Accolade, Inc.

Report date April 08, 2025 · Filed April 08, 2025

Section 16 reporting ended · disclosed 2025-04-08. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2025-04-08 transaction · row 1 1 source row Row 1 · 2025-04-08 · Disposition to issuer · Disposed 28,329 · Balance 0 F1: Reflects disposition of the Issuer's equity securities upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 8, 2025, by and among Issuer, Transcarent, Inc. ("Parent") and Acorn Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger (the "Merger") between Issuer and Merger Sub on April 8, 2025. Pursuant to the Merger Agreement, as of the effective time of the Merger (the "Effective Time"), each share of the Issuer's Common Stock, par value $0.0001 per share ("Shares") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $7.03 in cash, without interest (the "Merger Consideration").
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2025-04-08 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2025-04-08 · Disposition to issuer · Disposed 35,021 · Balance 0 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. RSUs convert into the Issuer's Common Stock on a one-for-one basis. F4: Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the Effective Time that is vested, after giving effect to any applicable vesting acceleration and separation right applicable to any individual other than a continuing employee, (each, a "Vested Company RSU") and restricted stock units outstanding immediately prior to the Effective Time that vest, or become eligible to vest, based on the achievement of performance conditions and that are vested or that will become vested as of immediately prior to the Effective Time, after giving effect to any applicable vesting acceleration and separation right applicable to any individual other than a continuing employee (each, a "Vested Company PSU") will be cancelled and converted into the right to receive the Merger Consideration, less any applicable tax withholdings. F3: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) August 6, 2025 (the one year anniversary of the 2024 annual meeting date), subject to continued service as a director through each applicable vesting date.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.65 · Expires 2029-10-22	Direct	Reported balance After 2025-04-08 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2025-04-08 · Disposition to issuer · Disposed 20,000 · Balance 0 F6: Pursuant to the Merger Agreement, at the Effective Time, each stock option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F5: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of September 24, 2019 (the "September 2019 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the September 2019 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the September 2019 Vesting Commencement Date.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.50 · Expires 2030-06-19	Direct	Reported balance After 2025-04-08 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2025-04-08 · Disposition to issuer · Disposed 8,600 · Balance 0 F6: Pursuant to the Merger Agreement, at the Effective Time, each stock option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F7: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of June 20, 2020 (the "2020 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the 2020 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the 2020 Vesting Commencement Date.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects disposition of the Issuer's equity securities upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 8, 2025, by and among Issuer, Transcarent, Inc. ("Parent") and Acorn Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger (the "Merger") between Issuer and Merger Sub on April 8, 2025. Pursuant to the Merger Agreement, as of the effective time of the Merger (the "Effective Time"), each share of the Issuer's Common Stock, par value $0.0001 per share ("Shares") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $7.03 in cash, without interest (the "Merger Consideration").

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. RSUs convert into the Issuer's Common Stock on a one-for-one basis.

F3: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) August 6, 2025 (the one year anniversary of the 2024 annual meeting date), subject to continued service as a director through each applicable vesting date.

F4: Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the Effective Time that is vested, after giving effect to any applicable vesting acceleration and separation right applicable to any individual other than a continuing employee, (each, a "Vested Company RSU") and restricted stock units outstanding immediately prior to the Effective Time that vest, or become eligible to vest, based on the achievement of performance conditions and that are vested or that will become vested as of immediately prior to the Effective Time, after giving effect to any applicable vesting acceleration and separation right applicable to any individual other than a continuing employee (each, a "Vested Company PSU") will be cancelled and converted into the right to receive the Merger Consideration, less any applicable tax withholdings.

F5: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of September 24, 2019 (the "September 2019 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the September 2019 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the September 2019 Vesting Commencement Date.

F6: Pursuant to the Merger Agreement, at the Effective Time, each stock option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration.

F7: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of June 20, 2020 (the "2020 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the 2020 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the 2020 Vesting Commencement Date.

Apptio Inc

Report date January 10, 2019 · Filed January 12, 2019

Section 16 reporting ended · disclosed 2019-01-12. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	Reported balance After 2019-01-10 transaction · row 1 1 source row Row 1 · 2019-01-10 · Disposition to issuer · Disposed 13,337 · Balance 0 F1: Includes 4,652 restricted stock units that represent contingent rights to receive 4,652 shares of the Issuer's Class A Common Stock upon settlement, which vested solely as a result of the consummation of the merger agreement between Apptio, Inc., Bellevue Parent, LLC, and Bellevue Merger Sub, Inc. (the "Merger Agreement") and which were cancelled and automatically converted into the right to receive a cash payment of $38.00 per share. F2: Disposed of pursuant to the Merger Agreement. in exchange for a cash payment of $38.00 per share.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.01 · Expires 2023-11-07	Direct	Reported balance After 2019-01-10 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2019-01-10 · Disposition to issuer · Disposed 48,127 · Balance 0 F3: Consists of vested options which vested solely as a result of the consummation of the Merger Agreement, which were cancelled and automatically converted into the right to receive a cash payment of $38.00 per share, less the applicable exercise price of the option, subject to any required withholding of taxes. F4: 1/4th of the shares subject to the option became vested on November 8, 2014 and 1/48th of the shares subject to the option vest monthly thereafter. The option is subject to an early exercise right and may be exercised in full prior to the vesting of the shares underlying the option, subject to the issuer's right of repurchase.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.31 · Expires 2025-11-05	Direct	Reported balance After 2019-01-10 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2019-01-10 · Disposition to issuer · Disposed 30,000 · Balance 0 F5: Includes 22,455 vested options, which as of the consummation of the Merger Agreement were cancelled and automatically converted into the right to received $38.00 per share, less the applicable per share exercise price and subject to any applicable withholding taxes. F6: Includes 7,545 options, which vested solely as a result of the consummation of the Merger Agreement, which were cancelled and automatically converted into the right to receive a cash payment of $38.00 per share, less the applicable exercise price of the option, subject to any required withholding of taxes. F7: 1/3rd of the shares subject to the option shall become vested on September 29, 2017 and 1/36th of the shares subject to the option shall vest monthly thereafter for the next 24 months. The option is subject to an early exercise right and may be exercised in full prior to the vesting of the shares underlying the option, subject to the issuer's right of repurchase.

Filing footnotes · ownership attribution and instrument terms

F1: Includes 4,652 restricted stock units that represent contingent rights to receive 4,652 shares of the Issuer's Class A Common Stock upon settlement, which vested solely as a result of the consummation of the merger agreement between Apptio, Inc., Bellevue Parent, LLC, and Bellevue Merger Sub, Inc. (the "Merger Agreement") and which were cancelled and automatically converted into the right to receive a cash payment of $38.00 per share.

F2: Disposed of pursuant to the Merger Agreement. in exchange for a cash payment of $38.00 per share.

F3: Consists of vested options which vested solely as a result of the consummation of the Merger Agreement, which were cancelled and automatically converted into the right to receive a cash payment of $38.00 per share, less the applicable exercise price of the option, subject to any required withholding of taxes.

F4: 1/4th of the shares subject to the option became vested on November 8, 2014 and 1/48th of the shares subject to the option vest monthly thereafter. The option is subject to an early exercise right and may be exercised in full prior to the vesting of the shares underlying the option, subject to the issuer's right of repurchase.

F5: Includes 22,455 vested options, which as of the consummation of the Merger Agreement were cancelled and automatically converted into the right to received $38.00 per share, less the applicable per share exercise price and subject to any applicable withholding taxes.

F6: Includes 7,545 options, which vested solely as a result of the consummation of the Merger Agreement, which were cancelled and automatically converted into the right to receive a cash payment of $38.00 per share, less the applicable exercise price of the option, subject to any required withholding of taxes.

F7: 1/3rd of the shares subject to the option shall become vested on September 29, 2017 and 1/36th of the shares subject to the option shall vest monthly thereafter for the next 24 months. The option is subject to an early exercise right and may be exercised in full prior to the vesting of the shares underlying the option, subject to the issuer's right of repurchase.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 03, 2026 Filed Jun 5, 2026 20:45 UTC	Denali Therapeutics Inc. DNLI · Entity 1735	GrantStock Option (right to buy) · Derivative	19,226	$0.00 Strike: $19.66	$0.00	Disclosure SEC source: 0001478007-26-000002 · wk-form4_1780692356.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,226 Underlying: Common Stock · 19,226 shares Expires 2036-06-03 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document
June 03, 2026 Filed Jun 5, 2026 20:45 UTC	Denali Therapeutics Inc. DNLI · Entity 1735	GrantCommon Stock	6,408	$0.00	$0.00	Disclosure SEC source: 0001478007-26-000002 · wk-form4_1780692356.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,941 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 6,408 unvested RSUs. Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:31 UTC	Denali Therapeutics Inc. DNLI · Entity 1735	GrantStock Option (right to buy) · Derivative	18,111	$0.00 Strike: $13.93	$0.00	Disclosure SEC source: 0001714899-25-000140 · wk-form4_1749155428.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,111 Underlying: Common Stock · 18,111 shares Expires 2035-06-03 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:31 UTC	Denali Therapeutics Inc. DNLI · Entity 1735	GrantCommon Stock	6,037	$0.00	$0.00	Disclosure SEC source: 0001714899-25-000140 · wk-form4_1749155428.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,533 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 6,037 unvested RSUs. Read SEC document
April 08, 2025 Filed Apr 8, 2025 10:35 UTC	Accolade, Inc. ACCD · Entity 80959	Disposition to issuerStock Option (Right to Buy) · Derivative	8,600	Not disclosed Strike: $17.50	Not disclosed	Disclosure SEC source: 0001415889-25-010345 · form4-04082025_020402.xml · derivative · entry 4 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,600 shares Expires 2030-06-19 F6 · price: Pursuant to the Merger Agreement, at the Effective Time, each stock option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F7 · derivative.exercise_date: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of June 20, 2020 (the "2020 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the 2020 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the 2020 Vesting Commencement Date. Read SEC document
April 08, 2025 Filed Apr 8, 2025 10:35 UTC	Accolade, Inc. ACCD · Entity 80959	Disposition to issuerStock Option (Right to Buy) · Derivative	20,000	Not disclosed Strike: $13.65	Not disclosed	Disclosure SEC source: 0001415889-25-010345 · form4-04082025_020402.xml · derivative · entry 3 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2029-10-22 F6 · price: Pursuant to the Merger Agreement, at the Effective Time, each stock option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F5 · derivative.exercise_date: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of September 24, 2019 (the "September 2019 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the September 2019 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the September 2019 Vesting Commencement Date. Read SEC document
April 08, 2025 Filed Apr 8, 2025 10:35 UTC	Accolade, Inc. ACCD · Entity 80959	Disposition to issuerRestricted Stock Units · Derivative	35,021	Not disclosed	Not disclosed	Disclosure SEC source: 0001415889-25-010345 · form4-04082025_020402.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,021 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. RSUs convert into the Issuer's Common Stock on a one-for-one basis. F4 · price: Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the Effective Time that is vested, after giving effect to any applicable vesting acceleration and separation right applicable to any individual other than a continuing employee, (each, a "Vested Company RSU") and restricted stock units outstanding immediately prior to the Effective Time that vest, or become eligible to vest, based on the achievement of performance conditions and that are vested or that will become vested as of immediately prior to the Effective Time, after giving effect to any applicable vesting acceleration and separation right applicable to any individual other than a continuing employee (each, a "Vested Company PSU") will be cancelled and converted into the right to receive the Merger Consideration, less any applicable tax withholdings. F3 · derivative.exercise_date: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) August 6, 2025 (the one year anniversary of the 2024 annual meeting date), subject to continued service as a director through each applicable vesting date. F3 · derivative.expiration_date: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) August 6, 2025 (the one year anniversary of the 2024 annual meeting date), subject to continued service as a director through each applicable vesting date. Read SEC document
April 08, 2025 Filed Apr 8, 2025 10:35 UTC	Accolade, Inc. ACCD · Entity 80959	Disposition to issuerCommon Stock	28,329	$7.03	$199,152.87	Disclosure SEC source: 0001415889-25-010345 · form4-04082025_020402.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Reflects disposition of the Issuer's equity securities upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 8, 2025, by and among Issuer, Transcarent, Inc. ("Parent") and Acorn Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger (the "Merger") between Issuer and Merger Sub on April 8, 2025. Pursuant to the Merger Agreement, as of the effective time of the Merger (the "Effective Time"), each share of the Issuer's Common Stock, par value $0.0001 per share ("Shares") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $7.03 in cash, without interest (the "Merger Consideration"). Read SEC document
March 13, 2025 Filed Mar 14, 2025 23:10 UTC	F5, INC. FFIV · Entity 839	GrantRestricted Stock Unit · Derivative	934	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001048695-25-000055 · wk-form4_1741993838.xml · derivative · entry 3 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 934 Underlying: Common Stock · 934 shares Expires not disclosed F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date. F4 · derivative.exercise_date: Restricted Stock Units will fully vest on the first business day prior to the date of the annual shareholder meeting for fiscal 2025 (to be held in 2026) if the reporting person continues to serve as a director on the vest date, and the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date. F3 · derivative.expiration_date: If the reporting person continues to provide services to the Company through the vest date, the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date. Read SEC document
March 12, 2025 Filed Mar 14, 2025 23:10 UTC	F5, INC. FFIV · Entity 839	Exercise / conversionRestricted Stock Unit · Derivative	1,309	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001048695-25-000055 · wk-form4_1741993838.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,309 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date. F2 · derivative.exercise_date: Restricted Stock Units will fully vest on the first business day prior to the date of the annual shareholder meeting for fiscal 2024 (to be held in 2025) if the reporting person continues to serve as a director on the vest date, and the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date. F3 · derivative.expiration_date: If the reporting person continues to provide services to the Company through the vest date, the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date. Read SEC document
March 12, 2025 Filed Mar 14, 2025 23:10 UTC	F5, INC. FFIV · Entity 839	Exercise / conversionCommon Stock	1,309	$0.00	$0.00	Disclosure SEC source: 0001048695-25-000055 · wk-form4_1741993838.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
September 05, 2024 Filed Sep 6, 2024 21:22 UTC	F5, INC. FFIV · Entity 839	GiftCommon Stock	1,000	$0.00	$0.00	Disclosure SEC source: 0001048695-24-000140 · wk-form4_1725657761.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,024 Read SEC document
August 06, 2024 Filed Aug 8, 2024 14:25 UTC	Accolade, Inc. ACCD · Entity 80959	Exercise / conversionRestricted Stock Units · Derivative	9,196	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-24-021877 · form4.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,196 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F2 · price: Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F3 · derivative.exercise_date: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) August 8, 2024 (the one year anniversary measured from the 2023 annual meeting date), each subject to continued service as a director through each applicable vesting date. F3 · derivative.expiration_date: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) August 8, 2024 (the one year anniversary measured from the 2023 annual meeting date), each subject to continued service as a director through each applicable vesting date. Read SEC document
August 06, 2024 Filed Aug 8, 2024 14:25 UTC	Accolade, Inc. ACCD · Entity 80959	Exercise / conversionCommon Stock	9,196	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-24-021877 · form4.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") converted into one share of the Issuer's common stock. Read SEC document
August 06, 2024 Filed Aug 8, 2024 14:03 UTC	Accolade, Inc. ACCD · Entity 80959	GrantRestricted Stock Units · Derivative	35,021	$0.00	$0.00	Disclosure SEC source: 0001127602-24-021859 · form4.xml · derivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,021 Underlying: Common Stock · 35,021 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) August 6, 2025 (the one year anniversary of the 2024 annual meeting date), subject to continued service as a director through each applicable vesting date. F2 · derivative.expiration_date: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) August 6, 2025 (the one year anniversary of the 2024 annual meeting date), subject to continued service as a director through each applicable vesting date. Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:20 UTC	Denali Therapeutics Inc. DNLI · Entity 1735	GrantStock Option (right to buy) · Derivative	17,901	$0.00 Strike: $18.56	$0.00	Disclosure SEC source: 0001714899-24-000133 · wk-form4_1717539614.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,901 Underlying: Common Stock · 17,901 shares Expires 2034-05-31 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:20 UTC	Denali Therapeutics Inc. DNLI · Entity 1735	GrantCommon Stock	5,967	$0.00	$0.00	Disclosure SEC source: 0001714899-24-000133 · wk-form4_1717539614.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,496 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 5,967 unvested RSUs. Read SEC document
March 14, 2024 Filed Mar 15, 2024 20:54 UTC	F5, INC. FFIV · Entity 839	GrantRestricted Stock Unit · Derivative	1,309	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001048695-24-000033 · wk-form4_1710536051.xml · derivative · entry 3 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,309 Underlying: Common Stock · 1,309 shares Expires not disclosed F2 · security: Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date. F5 · derivative.exercise_date: Restricted Stock Units will fully vest on the first business day prior to the date of the annual shareholder meeting for fiscal 2024 (to be held in 2025) if the reporting person continues to serve as a director on the vest date, and the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date. F4 · derivative.expiration_date: If the reporting person continues to provide services to the Company through the vest date, the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date. Read SEC document
March 13, 2024 Filed Mar 15, 2024 20:54 UTC	F5, INC. FFIV · Entity 839	Exercise / conversionRestricted Stock Unit · Derivative	1,770	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001048695-24-000033 · wk-form4_1710536051.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date. F3 · derivative.exercise_date: Restricted Stock Units will fully vest on the first business day prior to the date of the annual shareholder meeting for fiscal 2023 (to be held in 2024) if the reporting person continues to serve as a director on the vest date, and the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date. F4 · derivative.expiration_date: If the reporting person continues to provide services to the Company through the vest date, the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date. Read SEC document
March 13, 2024 Filed Mar 15, 2024 20:54 UTC	F5, INC. FFIV · Entity 839	Exercise / conversionCommon Stock	1,770	$0.00	$0.00	Disclosure SEC source: 0001048695-24-000033 · wk-form4_1710536051.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares received upon vesting of the March 9, 2023 award of Restricted Stock Units. Read SEC document
September 05, 2023 Filed Sep 7, 2023 16:46 UTC	F5, INC. FFIV · Entity 839	GiftCommon Stock	1,200	$0.00	$0.00	Disclosure SEC source: 0001209191-23-048577 · doc4.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,254 Read SEC document
August 18, 2023 Filed Aug 22, 2023 15:31 UTC	Accolade, Inc. ACCD · Entity 80959	GrantRestricted Stock Units · Derivative	9,196	$0.00	$0.00	Disclosure SEC source: 0001127602-23-023059 · form4.xml · derivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,196 Underlying: Common Stock · 9,196 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) August 8, 2024 (the one year anniversary measured from the 2023 annual meeting date), each subject to continued service as a director through each applicable vesting date. F2 · derivative.expiration_date: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) August 8, 2024 (the one year anniversary measured from the 2023 annual meeting date), each subject to continued service as a director through each applicable vesting date. Read SEC document
July 25, 2023 Filed Jul 27, 2023 14:46 UTC	Accolade, Inc. ACCD · Entity 80959	Exercise / conversionRestricted Stock Units · Derivative	14,060	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-23-021383 · form4.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,060 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F2 · price: Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F3 · derivative.exercise_date: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) the one year anniversary measured from the date of grant, each subject to continued service as a director through each applicable vesting date. F3 · derivative.expiration_date: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) the one year anniversary measured from the date of grant, each subject to continued service as a director through each applicable vesting date. Read SEC document
July 25, 2023 Filed Jul 27, 2023 14:46 UTC	Accolade, Inc. ACCD · Entity 80959	Exercise / conversionCommon Stock	14,060	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-23-021383 · form4.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,133 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") converted into one share of the Issuer's common stock. Read SEC document
June 14, 2023 Filed Jun 16, 2023 22:04 UTC	Palladyne AI Corp. STRC · Entity 6068	GrantCommon Stock	195,059	$0.00	$0.00	Disclosure SEC source: 0001209191-23-038055 · doc4.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,066 F1 · balance_after: Includes 195,059 restricted stock units ("RSUs"), each RSU representing the right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of (i) the first anniversary of the date the award is granted or (ii) the day prior to the date of the next annual meeting of the Issuer's stockholders following the date the award was granted, in each case, subject to the Reporting Person continuing to be a Service Provider through the applicable vesting date. Read SEC document
June 01, 2023 Filed Jun 5, 2023 22:05 UTC	Denali Therapeutics Inc. DNLI · Entity 1735	GrantStock Option (right to buy) · Derivative	12,649	$0.00 Strike: $30.92	$0.00	Disclosure SEC source: 0001714899-23-000098 · wk-form4_1686002730.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,649 Underlying: Common Stock · 12,649 shares Expires 2033-06-01 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document
June 01, 2023 Filed Jun 5, 2023 22:05 UTC	Denali Therapeutics Inc. DNLI · Entity 1735	GrantCommon Stock	4,216	$0.00	$0.00	Disclosure SEC source: 0001714899-23-000098 · wk-form4_1686002730.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,529 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 4,216 unvested RSUs. Read SEC document
March 09, 2023 Filed Mar 10, 2023 22:04 UTC	F5, INC. FFIV · Entity 839	GrantRestricted Stock Unit · Derivative	1,770	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-23-017862 · doc4.xml · derivative · entry 3 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,770 Underlying: Common Stock · 1,770 shares Expires not disclosed F2 · security: Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date. F4 · derivative.exercise_date: Restricted Stock Units will fully vest on the first business day prior to the date of the annual shareholder meeting for fiscal 2023 (to be held in 2024) if the reporting person continues to serve as a director on the vest date, and the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date. F5 · derivative.expiration_date: If the reporting person continues to provide services to the Company through the vest date, the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date. Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:04 UTC	F5, INC. FFIV · Entity 839	Exercise / conversionRestricted Stock Unit · Derivative	1,272	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-23-017862 · doc4.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,272 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date. F3 · derivative.expiration_date: One share of Common Stock of F5, Inc. was delivered to the reporting person for each Restricted Stock Unit that vested on March 8, 2023. Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:04 UTC	F5, INC. FFIV · Entity 839	Exercise / conversionCommon Stock	1,272	$0.00	$0.00	Disclosure SEC source: 0001209191-23-017862 · doc4.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares received upon vesting of the March 10, 2022 award of Restricted Stock Units. Read SEC document
February 28, 2023 Filed Mar 2, 2023 13:01 UTC	Accolade, Inc. ACCD · Entity 80959	Exercise / conversionRestricted Stock Units · Derivative	604	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-23-008185 · form4.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 604 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F2 · price: Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F3 · derivative.exercise_date: The shares subject to this RSU shall vest at a rate of twenty-five percent of the total number of shares on the last day of each quarter following March 1, 2022 (the "Vesting Commencement Date") for so long as the recipient of the RSU provides Continuous Service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: The shares subject to this RSU shall vest at a rate of twenty-five percent of the total number of shares on the last day of each quarter following March 1, 2022 (the "Vesting Commencement Date") for so long as the recipient of the RSU provides Continuous Service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date. Read SEC document
February 28, 2023 Filed Mar 2, 2023 13:01 UTC	Accolade, Inc. ACCD · Entity 80959	Exercise / conversionCommon Stock	604	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-23-008185 · form4.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") converted into one share of Common Stock upon vesting of the RSU. Read SEC document
November 30, 2022 Filed Dec 2, 2022 08:30 UTC	Accolade, Inc. ACCD · Entity 80959	Exercise / conversionRestricted Stock Units · Derivative	603	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-22-026674 · form4.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 604 Underlying: Common Stock · 603 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F2 · price: Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F3 · derivative.exercise_date: The shares subject to this RSU shall vest at a rate of twenty-five percent of the total number of shares on the last day of each quarter following March 1, 2022 (the "Vesting Commencement Date") for so long as the recipient of the RSU provides Continuous Service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: The shares subject to this RSU shall vest at a rate of twenty-five percent of the total number of shares on the last day of each quarter following March 1, 2022 (the "Vesting Commencement Date") for so long as the recipient of the RSU provides Continuous Service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date. Read SEC document
November 30, 2022 Filed Dec 2, 2022 08:30 UTC	Accolade, Inc. ACCD · Entity 80959	Exercise / conversionCommon Stock	603	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-22-026674 · form4.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") converted into one share of Common Stock upon vesting of the RSU. Read SEC document
August 31, 2022 Filed Sep 1, 2022 11:27 UTC	Accolade, Inc. ACCD · Entity 80959	Exercise / conversionRestricted Stock Units · Derivative	604	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-22-021830 · form4.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,207 Underlying: Common Stock · 604 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F2 · price: Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F3 · derivative.exercise_date: The shares subject to this RSU shall vest at a rate of twenty-five percent of the total number of shares on the last day of each quarter following March 1, 2022 (the "Vesting Commencement Date") for so long as the recipient of the RSU provides Continuous Service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: The shares subject to this RSU shall vest at a rate of twenty-five percent of the total number of shares on the last day of each quarter following March 1, 2022 (the "Vesting Commencement Date") for so long as the recipient of the RSU provides Continuous Service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date. Read SEC document
August 31, 2022 Filed Sep 1, 2022 11:27 UTC	Accolade, Inc. ACCD · Entity 80959	Exercise / conversionCommon Stock	604	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-22-021830 · form4.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") converted into one share of Common Stock upon vesting of the RSU. Read SEC document
July 26, 2022 Filed Jul 27, 2022 13:09 UTC	Accolade, Inc. ACCD · Entity 80959	GrantRestricted Stock Units · Derivative	14,060	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-22-019809 · form4.xml · derivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,060 Underlying: Common Stock · 14,060 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F1 · price: Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F2 · derivative.exercise_date: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) the one year anniversary measured from the date of grant, each subject to continued service as a director through each applicable vesting date. F2 · derivative.expiration_date: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) the one year anniversary measured from the date of grant, each subject to continued service as a director through each applicable vesting date. Read SEC document
July 21, 2022 Filed Jul 25, 2022 10:41 UTC	Accolade, Inc. ACCD · Entity 80959	Exercise / conversionRestricted Stock Units · Derivative	2,659	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-22-019692 · form4.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,659 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F2 · price: Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F3 · derivative.exercise_date: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) the one year anniversary measured from the date of grant, each subject to continued service as a director through each applicable vesting date. F3 · derivative.expiration_date: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) the one year anniversary measured from the date of grant, each subject to continued service as a director through each applicable vesting date. Read SEC document
July 21, 2022 Filed Jul 25, 2022 10:41 UTC	Accolade, Inc. ACCD · Entity 80959	Exercise / conversionCommon Stock	2,659	$9.67	$25,712.53	Disclosure SEC source: 0001127602-22-019692 · form4.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") converted into one share of Common Stock upon vesting of the RSU. Read SEC document
June 29, 2022 Filed Jun 30, 2022 22:56 UTC	Palladyne AI Corp. STRC · Entity 6068	GrantCommon Stock	57,692	$0.00	$0.00	Disclosure SEC source: 0001209191-22-039962 · doc4.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,007 F1 · balance_after: Includes 57,692 restricted stock units ("RSUs"), each RSU representing the right to receive one share of common stock of Sarcos Technology and Robotics Corporation (the "Company"). The RSUs will vest on the earlier of (i) the first anniversary of the date the award is granted or (ii) the day prior to the date of the annual meeting of the Company's stockholders (the "Annual Meeting") next following the date the award was granted, in each case, subject to the Recipient continuing to be a Service Provider through the applicable vesting date. F2 · balance_after: Includes 12,315 shares of Common Stock underlying RSUs that fully vested on June 28, 2022. Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:09 UTC	Denali Therapeutics Inc. DNLI · Entity 1735	GrantStock Option (right to buy) · Derivative	17,959	$0.00 Strike: $24.27	$0.00	Disclosure SEC source: 0001714899-22-000097 · wf-form4_165456056392230.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,959 Underlying: Common Stock · 17,959 shares Expires 2032-06-02 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:09 UTC	Denali Therapeutics Inc. DNLI · Entity 1735	GrantCommon Stock	5,986	$0.00	$0.00	Disclosure SEC source: 0001714899-22-000097 · wf-form4_165456056392230.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,313 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document
May 31, 2022 Filed Jun 2, 2022 09:50 UTC	Accolade, Inc. ACCD · Entity 80959	Exercise / conversionRestricted Stock Units · Derivative	603	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-22-016267 · form4.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,811 Underlying: Common Stock · 603 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F2 · price: Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F3 · derivative.exercise_date: The shares subject to this RSU shall vest at a rate of twenty-five percent of the total number of shares on the last day of each quarter following March 1, 2022 (the "Vesting Commencement Date") for so long as the recipient of the RSU provides Continuous Service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date. Read SEC document
May 31, 2022 Filed Jun 2, 2022 09:50 UTC	Accolade, Inc. ACCD · Entity 80959	Exercise / conversionCommon Stock	603	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-22-016267 · form4.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") converted into one share of Common Stock upon vesting of the RSU. Read SEC document
March 10, 2022 Filed Mar 11, 2022 19:39 UTC	F5, INC. FFIV · Entity 839	GrantRestricted Stock Unit · Derivative	1,272	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-22-018132 · doc4.xml · derivative · entry 3 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,272 Underlying: Common Stock · 1,272 shares Expires not disclosed F2 · security: Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date. F4 · derivative.exercise_date: Restricted Stock Units will fully vest on the first business day prior to the date of the annual shareholder meeting for fiscal 2022 (to be held in 2023) if the reporting person continues to serve as a director on the vest date, and the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date. F5 · derivative.expiration_date: If the reporting person continues to provide services to the Company through the vest date, the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date. Read SEC document
March 09, 2022 Filed Mar 11, 2022 19:39 UTC	F5, INC. FFIV · Entity 839	Exercise / conversionRestricted Stock Unit · Derivative	1,282	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-22-018132 · doc4.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date. F3 · derivative.expiration_date: One share of Common Stock of F5, Inc. was delivered to the reporting person for each Restricted Stock Unit that vested on March 9, 2022. Read SEC document
March 09, 2022 Filed Mar 11, 2022 19:39 UTC	F5, INC. FFIV · Entity 839	Exercise / conversionCommon Stock	1,282	$0.00	$0.00	Disclosure SEC source: 0001209191-22-018132 · doc4.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares received upon vesting of the March 11, 2021 award of Restricted Stock Units. Read SEC document
March 01, 2022 Filed Mar 2, 2022 10:17 UTC	Accolade, Inc. ACCD · Entity 80959	GrantRestricted Stock Units · Derivative	2,414	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-22-007518 · form4.xml · derivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,414 Underlying: Common Stock · 2,414 shares Expires 2026-03-01 F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F2 · derivative.exercise_date: The shares subject to this RSU shall vest at a rate of twenty-five percent of the total number of shares on the last day of each quarter following March 1, 2022 (the "Vesting Commencement Date") for so long as the recipient of the RSU provides Continuous Service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date. Read SEC document
December 09, 2021 Filed Dec 29, 2021 22:05 UTC	Palladyne AI Corp. STRC · Entity 6068	GrantCommon Stock	12,315	$0.00	$0.00	Disclosure SEC source: 0001209191-21-071487 · doc4.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,315 F1 · shares: Represents restricted stock units ("RSUs"), each RSU representing the right to receive one share of common stock of Sarcos Technology and Robotics Corporation (the "Company"). The RSUs will vest on the earlier of (i) the first anniversary of the date the award is granted or (ii) the day prior to the date of the annual meeting of the Company's stockholders (the "Annual Meeting") next following the date the award was granted, in each case, subject to the Recipient continuing to be a Service Provider through the applicable vesting date. Read SEC document
July 22, 2021 Filed Jul 26, 2021 13:52 UTC	Accolade, Inc. ACCD · Entity 80959	GrantRestricted Stock Units · Derivative	2,659	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-21-022489 · form4.xml · derivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,659 Underlying: Common Stock · 2,659 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Common Stock upon vesting of the RSU. F2 · derivative.exercise_date: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) the one year anniversary measured from the date of grant, each subject to continued service as a director through each applicable vesting date. F2 · derivative.expiration_date: The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) the one year anniversary measured from the date of grant, each subject to continued service as a director through each applicable vesting date. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.